Drug
Intradialytic Parenteral Nutrition
Intradialytic Parenteral Nutrition: highest development phase Post-Market, developed by Fresenius Kabi. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Fresenius Kabi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Intradialytic Parenteral Nutrition (IDPN) NCT00501956 | Post-Market | Malnutrition |
Latest
No recent events.
Follow Intradialytic Parenteral Nutrition on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.